Related Experiment Video
Updated: Jul 8, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Screening and comparative study of four anti-PEDV candidate drugs in vitro
Yiyi Hu1, Yunchuan Li1, Haodan Zhu1
1Jiangsu Key Laboratory for Food Quality and Safety-State Key Laboratory Cultivation Base of Ministry of Science and Technology, Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing, 210014, China; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Disease and Zoonose, Yangzhou University, Yangzhou, 225009, China; GuoTai (Taizhou) Center of Technology Innovation for Veterinary Biologicals, Taizhou, 225300, China.
Abstract:
Piglets afflicted with Porcine Epidemic Diarrhea Virus (PEDV) experience severe diarrhea and elevated death rates, leading to substantial financial losses in the pig farming sector. The objective of this study is to investigate the impact of polyphenols on PEDV within Vero cells by utilizing different methodologies to evaluate their anti-PEDV effect. By producing 30 polyphenols, we have discovered that No.2, No.5, No.7 and No.17 exhibit properties that make them effective against PEDV, serving as potential drugs. The findings showed that in a clear dose-dependent manner, the mRNA levels of PEDV were significantly inhibited in the high, middle, and low-dose groups of No.2, No.5, No.7 and No.17, when compared to the PEDV control. The four tested polyphenols significantly inhibited the levels of PEDV N contents and viral titers. Furthermore, concentration of cytotoxicity 50 % (CC50) values for No.2, No.5, No.7 and No.17 polyphenols were 42.84 μM, 16.78 μM, 39.01 μM and 28.86 μM, respectively, demonstrating the safety of these medications in clinical environments. While they exert their anti-PEDV activity all specifically at the viral replication stage. Collectively, these findings indicate that the four examined polyphenols could efficiently modulate the immune response against PEDV and hold promise for utilization in antiviral treatments.

